Setting a gold standard in meeting cannabis regulation
Written By
Partner
UK
As one of our firm's most experienced intellectual property partners, specialising in transactional IP matters, I offer a wealth of knowledge to businesses at the cutting edge of research, development and technology, in a variety of sectors for which IP is of prime importance.
Medical Cannabis Network speaks with Bird & Bird’s Ben King and Sally Shorthose about the importance of product labelling and the regulation of medical cannabis.
Bird & Bird know that the issue of labelling medical cannabis products can be a confusing and challenging issue for new market entrants. It is important that the product be clearly classified as being either medicinal or recreational. The labelling of some products has been exploited, allowing them to be marketed as something they are not and undermining consumer confidence in the product.
Latest insights
More Insights
Women in Tech: At the forefront of innovation - Key takeaways from Dana Ghosn, Typeless
3 minutes Aug 07 2025
German Constitutional Court upholds pharmaceutical cost control measures: implications for drug pricing and reimbursement
5 minutes Aug 05 2025
UK-India Trade: Opportunities for UK business under the new Free Trade Agreement
3 minutes May 19 2025